Lymphoma Highlights and Key Takeaways from the 2026 ASCO Annual Meeting

Dr. Joshua Brody provides an expert overview of the most impactful clinical updates and essential takeaways from the 2026 ASCO Annual Meeting, focusing on groundbreaking advancements in lymphoma care. The recap explores the latest data on bispecific antibodies, including remarkable complete remission rates in Mantle Cell Lymphoma, crucial safety updates for outpatient administration, and the rapidly evolving role of frontline combination therapies in DLBCL.